Results 71 - 80 of 119 : Previous 4 5 6 7 8 9 10 11 12 Next
The CAPS Screen: 5 Small Caps on Fire
Sometimes doubles can lead to home runs.
Maybe what glitters really is gold.
Maybe what glitters really is gold.
Does Vertex's telaprevir really trump Schering's boceprevir?
ViroPharma: Risky and Exciting
Solid lead drug, meet promising pipeline candidate.
The End for (Another) Hepatitis C Drug Candidate
ViroPharma stops development of its compound after data showed it may hurt the liver.
Maybe what glitters really is gold.
We zero in on some of the top cash-generating companies today.
Nektar announces its guidance for 2008.
Sales of its antibiotic are slowing down, but there is a promising drug in its pipeline.